CClinicalTrials.gg
Status unknownNCT02952768Updated Feb 23, 2017

The Novel US-C-A-B Protocol: Curriculum Implementation and Evaluation of Proficiency

An interventional study of ultrasound training in Ultrasound Therapy; Complications, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to participants aged 25 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-02-23.

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Other

The sponsor has not verified this record recently (last verified Oct 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
25 Years to 60 Years
Sex
All
01

Study summary

Ultrasound is a frequently used diagnostic tool in the emergency department and suggested to have a role during resuscitation. The aims of this study were to develop a novel, resuscitative ultrasound-circulation-airway-breathing (US-C-A-B) protocol, to implement a short curriculum and to assess the feasibility.

The US-C-A-B protocol was built in an advanced life support-compliant manner. It involved a 3-part assessment: (1) C: subxiphoid 4-chamber view of the heart; (2) A: tracheal ultrasound; and (3) B: bilateral lung sliding. It could be used for direct confirmation for the C-A-B and searching the possible cause of cardiac arrest.

A half-day curriculum was designed, and comprised of one-hour didactics and 3-hour small-group hand-on training. Assessments were performed, including a written test, the US image acquisition and a satisfaction survey. From August 1, 2014 to March 31, 2016, the multi-center emergency physicians who attended the US-C-A-B curricula were enrolled prospectively.

Read the detailed description

Ultrasound is a frequently used diagnostic tool in the emergency department and suggested to have a role during resuscitation. The aims of this study were to develop a novel, resuscitative ultrasound-circulation-airway-breathing (US-C-A-B) protocol, to implement a short curriculum and to assess the feasibility.

The US-C-A-B protocol was built in an advanced life support-compliant manner. It involved a 3-part assessment: (1) C: subxiphoid 4-chamber view of the heart; (2) A: tracheal ultrasound; and (3) B: bilateral lung sliding. It could be used for direct confirmation for the C-A-B and searching the possible cause of

02

Conditions studied

  • Ultrasound Therapy; Complications
03

In context

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • The enrolled participants were emergency physicians of the National Taiwan University Hospital (NTUH), the Far-Eastern Memorial Hospital (FEMH) and the Chang-Kung Memorial Hospital (CKMH), three teaching hospitals in Taiwan.

Exclusion criteria

Exclusion Criteria:

  • Not emergency physicians.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Other
    ultrasound training

    The aims were to develop a novel, resuscitative ultrasound-circulation-airway-breathing (US-C-A-B) protocol, to implement a short curriculum for ultrasound training and to assess the feasibility.

    Behavioral: ultrasound training

Interventions

  • Behavioralultrasound training

    Through the ultrasound-circulation-airway-breathing training curriculum to integrate the ultrasound into clinical practice.

06

What researchers measure

Primary outcomes

  1. The time of the US image acquisition

    The 6-month evaluation was performed in cardiac arrest patients. The ultrasound operation time was from the time to initiate the ultrasound exam to when the sonographers to inteprete the results, using the ultrasound recorder.

    Time frame: 6 months

Secondary outcomes

  1. Learning efficacy was assessed with a written test with 10 multi-choice questions.

    The written test with 10 multi-choice questions, including ALS knowledge, and still US image interpretation of C-A-B was performed before and after completion of the course.

    Time frame: through study completion, an average of 1 year

  2. A satisfaction survey with a 5-point Likert scale.

    The post-course satisfaction survey queried the participants in regards to educational value, knowledge acquisition and self-confidence at the end of the course. The survey consisted of 5 items, using a 5-point Likert scale.

    Time frame: through study completion, an average of 1 year

  3. The time of the US image acquisition

    The participants were asked for to produce adequate views of each C-A-B category and consecutive C-A-B exams in the same live model after completion, recorded by the DVD recorder. The time to achieve the views was measured from positioning of the probe on the skin to maintaining an adequate image for at least 3 seconds. The videos were edited that the faces of the participants were covered, and reviewed blindly and independently by the authors. The 6-month evaluation was performed in cardiac arrest patients. The ultrasound operation time was from the time to initiate the ultrasound exam to when the sonographers to inteprete the results, using the ultrasound recorder.

    Time frame: through study completion, an average of 1 year

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02952768
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Nov 2, 2016
Start date
Aug 2014
Primary completion
Dec 2017 (estimated)
Completion
Dec 2017 (estimated)
Last update
Feb 23, 2017

Study contacts

Wan-Ching Lien, Ph. D.
Contact
wanchinglien@ntu.edu.tw
886-2-23123456 ext. 65637
Wan-Ching Lien, Ph.D.
study director · National Taiwan University Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion